Why High IV Matters for Sellers
When you sell a strangle, your edge comes from collecting premium that exceeds the stock's actual movement. High IV creates this edge because:
A strangle that collects $2.00 on a stock with 25% IV might collect $4.50 on the same stock at 55% IV. That's more than double the premium — and your breakevens are proportionally wider.
Identifying High-IV Candidates
IV Rank
IV Rank measures where current IV sits relative to the past year's range.
Formula: (Current IV - 52-week Low IV) / (52-week High IV - 52-week Low IV) × 100
IV Percentile
IV Percentile measures what percentage of days in the past year had lower IV than today.
What Causes High IV?
Avoid selling into binary events (earnings, FDA) unless you specifically want that risk. The best setups are stocks where IV is high because of recent market action, not because of an imminent catalyst.
Structuring the Short Strangle
Step 1: Filter for stocks with IV Rank > 50 and sufficient liquidity (average options volume > 1,000 contracts/day).
Step 2: Sell the 16-delta put and 16-delta call with 30-45 DTE.
Step 3: Verify the credit is at least 10% of the width between strikes. If the strikes are $20 apart and you're collecting less than $2.00, the trade isn't paying enough for the risk.
Step 4: Check the profit zone. Your breakevens should encompass the stock's typical 30-day range with room to spare.
Example Trade
Stock ABC at $80. IV Rank: 72. 30-day IV: 48%.
Breakevens: $71 and $89 — an $18 range (22.5% of stock price)
Max profit: $300 per contract (if ABC stays between $74 and $86) Probability of profit: ~68% (based on 1 SD)
Stock Selection Criteria
Not all high-IV stocks are good strangle candidates. Filter for:
| Criteria | Why It Matters |
Common Mistakes
Selling into earnings. Yes, IV is highest before earnings. But the stock can move 15%+ and blow past your strikes. Post-earnings IV crush helps, but it can't overcome a 15% gap.
Ignoring correlation. Selling strangles on AAPL, MSFT, GOOGL, AMZN, and META simultaneously isn't diversification — it's one big tech bet. If the sector sells off, all five positions lose.
Chasing premium. The highest IV stocks are often the riskiest. A biotech with 120% IV is expensive for a reason. Stick to liquid, well-established companies where high IV is more likely to mean-revert.
Not adjusting. When one side is tested, act. Don't sit and hope. Have a plan before entering the trade.
Risk-Adjusted Returns
Over long periods, selling strangles on high-IV stocks (IV Rank > 50) outperforms selling on low-IV stocks. The additional premium collected more than compensates for the occasional larger move.
Historical backtests show:
The higher premium from high-IV trades makes winners bigger and losses more manageable.
OptionsPilot's IV screening tools make it easy to find stocks with elevated IV Rank, no imminent earnings, and sufficient liquidity — the three ingredients for a high-quality short strangle setup.